Get an alert when a recall is issued.
There is currently no warning information available for this product. We apologize for any inconvenience.
There is currently no manufacturer warning information available for this drug.
Pentazocine Hydrochloride and Naloxone Hydrochloride Tablets, USP is indicated for the relief of moderate to severe pain.
Pentazocine Hydrochloride and Naloxone Hydrochloride Tablets, USP is indicated for oral use only.
Pentazocine Hydrochloride and Naloxone Hydrochloride Tablets contains pentazocine hydrochloride, USP, equivalent to 50 mg base and is a member of the benzazocine series (also known as the benzomorphan series), and naloxone hydrochloride, USP, equivalent to 0.5 mg base.
Pentazocine Hydrochloride and Naloxone Hydrochloride Tablets, USP is an analgesic for oral administration.
Chemically, pentazocine hydrochloride is (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol hydrochloride, a white, crystalline substance soluble in acidic aqueous solutions, and has the following structural formula:
Chemically, naloxone hydrochloride is Morphinan-6-one,4,5-epoxy-3,14-dihydroxy-17-(2propenyl)-, hydrochloride, (5α)-. It is a slightly off-white powder, and is soluble in water and dilute acids, and has the following structural formula:
